Intelligence · Patents
Expiring patents (≤24 months)
Patent cliff watchlist — pharmaceutical patents approaching loss of exclusivity.
- Patents
- 1,230
Quick answer
1,230 pharmaceutical patents in our index expire within the next 24 months. Use year facets below for annual patent-cliff planning linked to company and drug profiles.
-
US 7205305
Inhibitors of p38
granted -
US 7205334
Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
granted -
US 7205411
Aminopyridine derivatives as mGluR5 antagonists
granted -
US 7205005
Medicament containing epidemium extract for treatment of prostatic hyperplasia and prostatitis
granted -
US 7204982
Compositions and methods for treatment and detection of multiple cancers
granted -
US 7204993
Streptococcus agalactiae vaccine
granted -
US 7204996
Method of cancer treatment
granted -
US 7205006
Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
granted -
US 7205327
Imidazole and benzimidazole caspase inhibitors and uses thereof
granted -
US 7205380
Sterically hindered poly (ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 7208471
Glycopeptide phosphonate derivatives
granted -
US 7208580
Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds
granted -
US 7208289
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
granted -
US 7208145
Polymeric reagents comprising a ketone or a related functional group
granted -
US 7208313
Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
granted -
US 7208161
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
granted -
US 7208171
Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
granted -
US 7208154
Methods and compositions for the treatment of MHC-associated conditions
granted -
US 7208495
Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
granted -
US 7208501
Quinuclidine carbamate derivatives and their use as M3 antagonists
granted -
US 7208515
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted -
US 7208478
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
granted -
US 7208579
IL4 receptor antagonists for horse, dog and cat
granted -
US 7208612
Crystals of LuxP and complexes thereof
granted -
US 7208600
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
granted -
US 7208602
Gamma secretase inhibitors
granted -
US 7211445
Conjugation of biomolecules using diels-alder cycloaddition
granted -
US 7211432
Recombinant vector expressing multiple costimulatory molecules and uses thereof
granted -
US 7211192
Hybrid organic-inorganic adsorbents
granted -
US 7211252
Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
granted -
US 7211255
Contraceptives based on SP22 and SP22 antibodies
granted -
US 7211402
Transcription factor coactivator protein, p/CIP
granted -
US 7211599
Use of etodolac to treat hyperplasia
granted -
US 7214512
Genomic mammary Amyloid a sequence
granted -
US 7214687
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 7214784
Protective antigens for the control of Ixodes species infestations
granted -
US 7214366
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
granted -
US 7214391
Botanical extract compositions and process for preparing same
granted -
US 7214495
Screening method
granted -
US 7214519
Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using αβCys105 mutant sGC
granted -
US 7214690
Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
granted -
US 7214524
Marek's disease virus vaccine
granted -
US 7216041
Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket
granted -
US 7214787
Recombinant vaccine against botulinum neurotoxin
granted -
US 7217719
Spiroazacyclic compounds as monoamine receptor modulators
granted -
US 7217785
Cysteine-containing peptides having antioxidant properties
granted -
US 7217812
Extraneous DNA sequence that facilitates hantavirus gene expression
granted -
US 7217418
Multivalent dengue virus vaccine
granted
Frequently asked questions
What is a patent cliff?
A patent cliff is when key pharmaceutical patents expire, opening markets to generics or biosimilars. This hub lists USPTO patents with approaching expiration dates.
Are expiration dates estimates?
Expiration dates derive from USPTO PatentsView grant dates and term estimates. Confirm with Orange Book, patent counsel, and USPTO records before investment decisions.